ChinaBiz Briefing: Xiaomi’s AI Gambit, A GPU IPO Boom, and Pop Mart’s “Fashion Fatigue”
The Big Picture: Today’s cycle highlights the dual speeds of China’s economy: a roaring appetite for hard-tech autonomy contrasted with a volatile consumer landscape. While Xiaomi and MetaX double down on domestic AI and semiconductor infrastructure with aggressive pricing and soaring valuations, the consumer sector faces a reckoning as “hype fatigue” threatens darling brands like Pop Mart, even as budget players like Mixue push into the U.S. market.
Xiaomi Unleashes “Flash” Model to Rival DeepSeek What Happened: Smartphone giant Xiaomi pushed deeper into the AI wars with the release of MiMo-V2-Flash, an open-source model claiming to match the performance of competitors like DeepSeek-V3.2. Notably, Xiaomi is attacking on price and efficiency, offering inference speeds of 150 tokens per second at extremely low costs (0.1−0.1−0.3 per million tokens) and optimizing the model to run on consumer devices.
Why it matters: This signals a "race to the bottom" for AI inference costs in China, comparable to how Xiaomi disrupted smartphone pricing in 2011. Unlike pure software plays, Xiaomi is leveraging this model to fortify its hardware ecosystem (phones, IoT, EVs). By open-sourcing the tech, they are accelerating the commoditization of LLMs, pressuring proprietary models to demonstrate unique value beyond raw compute.
GPU Maker MetaX Explodes 569% in Market Debut What Happened: MetaX Integrated Circuits listed on the Shanghai STAR Market, with shares soaring 569% on day one to reach a peak valuation of over 270 billion yuan ($37.2 billion). The company, founded by former AMD executives, is the second domestic GPU maker to list recently, raising funds to develop alternatives to Nvidia’s chips despite currently operating at a loss.
Why it matters: The explosion in share price reflects intense investor appetite—and implied state support—for semiconductor self-sufficiency amid U.S. sanctions. With Nvidia restricted from selling top-tier chips to China, the capital markets are effectively underwriting a "whatever it takes" approach to building domestic replacements. The valuation is divorced from current fundamentals (revenue is growing, but losses persist) and is a pure bet on the strategic necessity of an indigenous supply chain.
Pop Mart Downgraded as “Fashion Fatigue” Sets In What Happened: Deutsche Bank downgraded toy giant Pop Mart to "Hold," triggering fears that the brand's boom cycle is peaking. Analysts argue that Pop Mart has become a victim of its own supply chain efficiency: by flooding the market with its signature "Labubu" figures (145 million units), it eliminated the scarcity that drove collector frenzy and high secondary market prices.
Why it matters: This is a sobering case study on the fragility of "hype economies." It suggests Pop Mart risks following the "Sanrio Cycle" (Hello Kitty)—a boom-bust pattern where ubiquity kills brand heat. For investors, it highlights the danger of valuing trend-driven consumer companies like luxury goods makers; once the "cool factor" fades and queues disappear, operating leverage reverses quickly.
Budget Tea Giant Mixue Enters the US Market What Happened: Mixue, China’s largest bubble tea chain by store count, has opened its first U.S. location in Los Angeles (Hollywood), initiating a trial run with aggressive pricing (bundles for $3.99). The expansion targets price-sensitive Western consumers, following the brand’s massive success in saturating Asian markets with over 53,000 stores.
Why it matters: Mixue is testing whether its ultra-low-cost, high-efficiency supply chain model can disrupt the U.S. beverage market, where bubble tea typically sells for 6−6−8. If successful, it proves that Chinese "consumption downgrade" brands can export their deflationary tactics globally, challenging incumbents on margin and volume rather than brand prestige.
China Claims Breakthrough in Invasive Brain-Computer Interface What Happened: Chinese researchers have successfully enabled a paralyzed patient to control robotic arms and devices in 3D space using an invasive brain-computer interface (BCI). The clinical trial reportedly achieved signal processing speeds (under 100ms latency) that allow for near-natural interaction with physical objects, moving beyond simple 2D screen cursor control.
Why it matters: This positions Chinese biotech as a serious competitor to Elon Musk’s Neuralink. By mastering the hardware (minimally invasive sensors) and the decoding algorithms needed for 3D control, China is securing a foothold in the future medical rehabilitation market. It demonstrates that deep-tech R&D in China is advancing rapidly beyond digital infrastructure into complex biological engineering.
What to Watch Next Monitor GPU stock volatility on the STAR Market; after the initial IPO euphoria, companies like MetaX and Moore Threads will face pressure to show actual adoption rates in data centers replacing Nvidia. Also, watch for Pop Mart’s Q4 guidance—if sales slow sequentially, the "hype bust" narrative could drag down the broader Chinese consumer discretionary sector.